STOCK TITAN

Michelle Griffin sells 48,044 ADPT shares (ADPT) for $735K

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Michelle Griffin reported sales of Common Stock. The filing shows Ms. Griffin disposed of 48,044 shares on 03/03/2026 for $735,299.01. The form also lists 15,394 restricted shares associated with Morgan Stanley Smith Barney LLC dated 03/04/2026.

Positive

  • None.

Negative

  • None.

Insights

Routine Form 144 sale by an individual insider or related account.

The filing documents a reported sale of 48,044 shares on 03/03/2026 generating $735,299.01. This is presented as a disposal event under Form 144 reporting rules.

Timing and method details beyond the sale date and gross proceeds are not provided; subsequent filings would clarify if sales were executed under a plan or as part of other transactions.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did ADPT insider Michelle Griffin report on Form 144?

Michelle Griffin reported a sale of 48,044 shares on 03/03/2026, with reported gross proceeds of $735,299.01. The form also lists 15,394 restricted shares dated 03/04/2026 tied to Morgan Stanley Smith Barney LLC.

Does the filing state who received the proceeds from the sale?

The filing lists gross proceeds of $735,299.01 for the 48,044-share sale, but it does not specify the recipient party or how proceeds were allocated in the provided excerpt.

Are there securities listed for future sale in the filing?

Yes. The excerpt lists 15,394 restricted shares dated 03/04/2026 associated with Morgan Stanley Smith Barney LLC, identified under the securities to be sold section.

What dates are shown in the Form 144 excerpt for these transactions?

The sale transaction date is 03/03/2026 (48,044 shares). The securities-to-be-sold entry is dated 03/04/2026, and a filing/processing date of 03/11/2026 appears in the excerpt.

Does this Form 144 indicate whether the sale was part of a Rule 10b5-1 plan?

The provided excerpt does not state whether the reported sale was effected under a Rule 10b5-1 plan or other prearranged trading program; the filing content does not include that disclosure.
Adaptive Biotechnologies

NASDAQ:ADPT

View ADPT Stock Overview

ADPT Rankings

ADPT Latest News

ADPT Latest SEC Filings

ADPT Stock Data

2.19B
150.68M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
SEATTLE